Clinical Trial Update: Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO) [NA]

View source ↗

Summary

A terminated clinical trial evaluating thromboelastography (TEG) in patients requiring extracorporeal membrane oxygenation (ECMO) has posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Lung Disease

Snippet

Sponsor: Stephen Esper | Conditions: Heart Disease, Lung Disease | NA | Status: TERMINATED | Results posted: 2025-05-31